About the Company
Concert Pharmaceuticals is a clinical stage biopharmaceutical company that is developing small molecule drugs that it discovered through the application of its DCE Platform® (deuterated chemical entity platform). Selective incorporation of deuterium into known molecules has the potential, on a case-by-case basis, to provide better pharmacokinetic or metabolic properties, thereby enhancing their clinical safety, tolerability or efficacy. Concert's lead product candidate is in late-stage development for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert is also assessing a number of earlier-stage pipeline candidates.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $CNCE News
Best Companies To Short As Nasdaq And Tech Stocks Retreat
Our first Top Short is Concert Pharmaceuticals Inc, a clinical stage biopharmaceutical company that aims to discover and develop small-molecule drugs by incorporating new elements into known ...
With 66% ownership in Concert Pharmaceuticals, Inc. (NASDAQ:CNCE), institutional investors have a lot riding on the business
If you want to know who really controls Concert Pharmaceuticals, Inc. (NASDAQ:CNCE), then you'll have to look at the makeup of its share registry. And the group that holds the biggest piece of the pie ...
AI Models Say These Are The Best Stocks To Short Today
Price of Alpine Immune Sciences Inc compared to its Simple Moving Average Concert Pharmaceuticals Inc is the next Top Short today, with factor scores identified by our deep learning algorithms of ...
Concert Pharmaceuticals Announces Pricing of Public Offering
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced the pricing of an underwritten public offering of 10,000,000 shares of its common stock at a public offering price of $4.75 per share.
Flagship Ventures Fund 2004 L P's Net Worth
This is based on reported shares across multiple companies, which include TETRAPHASE PHARMACEUTICALS INC, BIND Therapeutics, Inc, Quanterix Corp, CONCERT PHARMACEUTICALS, INC., T2 Biosystems ...
India's Sun Pharma Posts Near-30% Rise In Q4 Profit On Lower Input Costs
Its global specialty drugs sales rose 28 percent. In March, Sun Pharma completed acquisition of U.S.-based Concert Pharmaceuticals Inc, giving it access to the company's late-stage drug ...
The 4th Annual Knox Rox Concert to Benefit the Hillcrest Healthcare Foundation and the Daily Living Center
Knox Rox concert will be Saturday, April 27, from 5-8 p.m. at 865 Axe Throwing, located in Northeast Knoxville at 5821 ...
Investors Shrug Off Nvidia’s ‘A.I. Woodstock’
(Huang said that the event was no rock concert, before making a joking reference to Taylor ... “The performance of generative ...
Plc Gsk's Net Worth
Plc Gsk has an estimated net worth of $9.11 Billion. This is based on reported shares across multiple companies, which include Wave Life Sciences Ltd., CVRx, Inc., Lyell Immunopharma, Inc ...
Jennifer Lopez 2024 tour stop canceled in Cleveland: Show called off at Rocket Mortage FieldHouse
Jennifer Lopez was scheduled to bring the 'This Is Me... Now' tour to Rocket Mortgage FieldHouse in Cleveland on Tuesday, Aug ...
The Rock takes aim at Ja Morant's gun troubles during live concert on WWE SmackDown in Memphis
It's typical for heels -- villainous wrestlers -- to joke about sports teams from the host cities to get jeers from the fans in attendance. The Rock and his cousin, Roman Reigns, are currently ...
Ben Platt Will Play 3-Week Concert Residency at Broadway's Palace Theatre
Ben Platt will play a three-week concert residency at Broadway's recently refurbished Palace Theatre this May, in celebration ...
Loading the latest forecasts...